Tadmor T, Benjamini O, Goldschmidt N, Kreiniz N, Bairey O, Harel R, Sarid N, Levi T, Wolach O, Herishanu Y. Fixed-duration obinutuzumab-ibrutinib-venetoclax for Richter’s transformation: results from the phase II GIVeRS trial. haematol [Internet]. 2020Sep.10 [cited 2026May9];. Available from: https://haematologica.org/article/view/14169